Ikarian Capital »

Chemomab Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Chemomab Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $140k 53k 2.63

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Chemomab Therapeutics

Sphera Funds Management
Ikarian Capital
Stonepine Capital Management
Jane Street
Rhumbline Advisers
Bnp Paribas Arbitrage, Snc
GAMMA Investing
UBS Group
SBI Securities

View all funds holding Chemomab Therapeutics